All Type of News
‘GSK’ ranks the top in No. of products suspended in supply
A pharmaceutical company which caused the highest number of incidents of suspending pharmaceutical supply to hospitals was a global pharmaceutical company, ‘GlaxoSmithKline(GSK).’
Since medical services on patients h...
8 of 10 products approved this year were ‘ETC’
It was observed 8 of 10 pharmaceutical products approved this year were ETC drugs.
According to the Ministry of Food and Drug Safety’s Online Pharmaceutical Library, there were the total 2,779 products approved betwe...
Chong Kun Dang makes move to address shortage issue of Tamiflu
Chong Kun Dang(CEO Young-Joo Kim) announced to additionally supply the amount of Tamifly for 600 thousand people as the number of people infected by influenza reaches recently to the highest level.
Chong Kun Dang has...
“Obligation of generic name prescription is proven in effectiveness and strengths”
When it came to the Korean Medical Association’s opposition to the obligation of prescription with generic name on the 23rd, the Korean Pharmaceutical Association’s 16 regional associations council announced “As an or...
Series of listed pharmas to decide on free issuance of new shares and cash & share dividends
Listed pharmaceutical companies have returned a part of their profits to shareholders through cash and stock dividends and free issue of new shares before settling their accounts at the end of the year.
Among the lis...
Undecided direction on Korean distribution license for Gilead’s Sovaldi and Harvoni
It is hard to predict where the Korean distribution license of ‘Sovaldi’ and ‘Harvoni,’ Gilead Sciences’ chronic hepatitis C treatments that have drawn interests of both pharmaceutical and distribution industries as l...
Rapid growth of Dong Wha Pharm’s Each to stand the top in toothpaste-type gum treatment market
The Dong Wha Pharm’s paste-type gum therapy ‘Each’ has made a rapid growth.
According to the company, after recording KRW 3.7 billion sales after the release in 2011 with a concept called ‘gum treatment and tooth bru...
Alteogen completes clinical trial of ‘Herceptin’ biosimilar
Alteogen announced the Phase 1 clinical trial of a biosimilar of Herceptin, a breast cancer therapy, which has been conducted in Canada since February, was successfully completed.
Alteogen has carried out the Phase 1...
Hanmi’s Rosuzet achieves approx. KRW 20 billion sales only in a yearThe Hanmi Pharm’s(CEO Kwan-Sun Lee) hyperlipidemia therapy ‘Rosuzet’ achieved approximately KRW 20 billion sales(Jan 2016 to Nov 2016, based on UBIST) in a year after the launch...
|
Green Cross acquires WHO PQ for quadrivalent flu vaccineA tetravalent influenza(flu) vaccine certified by the international organization was developed in Korea for the second time in the world.
Green Cross(CEO Eun-Cheol Huh) announc...
|
